(Q48942237)

17 February 2018

title

Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. (English)

1 reference

17 February 2018

0 references

0 references

Bakshi R

1

1 reference

17 February 2018

Dmochowski J

series ordinal

2

1 reference

17 February 2018

Shaikh ZA

series ordinal

3

1 reference

17 February 2018

Jacobs L

series ordinal

4

1 reference

17 February 2018

publication date

1 March 2001

1 reference

17 February 2018

Journal of the Neurological Sciences

published in

1 reference

17 February 2018

volume

185

1 reference

17 February 2018

page(s)

19-26

1 reference

17 February 2018

issue

1

1 reference

17 February 2018

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Neuropathology in multiple sclerosis: new concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Axonal transection in the lesions of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Cortical lesions in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Cortical plaques visualised by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Defining the clinical course of multiple sclerosis: Results of an international survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Biological significance of iron-related magnetic resonance imaging changes in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

A decrease in cerebral cortex intensity on T2-weighted with ageing images of normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Brain MRI lesions and atrophy are related to depression in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Estimating the Dimension of a Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Multivariate Adaptive Regression Splines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

A Wallerian degeneration pattern in patients at risk for MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Signal intensity on MRI of basal ganglia in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Iron deposits in multiple sclerosis and Alzheimer's disease brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

Iron and oxygen radicals in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900477-4

10.1016/S0022-510X(01)00477-4

7 January 2021

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

11266686

1 reference

17 February 2018